Cephalon Australia (vic) Pty Ltd

Status: Registered
Current name since: 24th February 2010
Name in the ASICs register: Cephalon Australia (vic) Pty Ltd
Australian Company Number: 097483068
Australian Business Number: 33097483068
Registration date: 12th July 2001
Type: Australian proprietary company
Class: Limited by Shares
Subclass: Proprietary other
last updated

Description

Cephalon Australia (vic) Pty Ltd is a limited by shares Australian proprietary company. Located at NSW 2113 since 2015-06-19 the company is, as the updated on 2019-01-12 ABN database shows, registered. The company has been registered for Goods & Services Tax since 2001-07-13. Known company numbers for Cephalon Australia (vic) Pty Ltd are as follows: ACN - 097483068, Australian Business Number - 33097483068. Cephalon Australia (vic) Pty Ltd has been the company name since 2010-02-24. Evogenix is an example of a business name Cephalon Australia (vic) Pty Ltd used. The complete list includes 1 solitary business name. Evogenix was the company's business name from 2001-09-13 until 2010-12-15. Their official company name changed on 2007-12-03 to Arana Therapeutics (vic) Pty Ltd. The company had used this name up until 2010-02-24. Additionally they had used Evogenix Limited from 2005-07-08 to 2007-12-03, Evogenix Pty Limited from 2002-05-08 to 2005-07-08. This Australian proprietary company was previously located in VIC 3052 (from 2014-09-23 to 2015-06-19), VIC 3052 (from 2014-01-20 to 2014-09-23), VIC 3052 (from 2008-03-10 to 2014-01-20). We found 3 trademarks that reference this company. 2002-06-03 is the date the documents needed to start the registration process of trademark no 915085 were submitted. This trademark is categorised as "word" and its application status is "registered, live". Other company trademarks include trademark number 921009, application status "registered, live", registered on 2002-07-24 in the "word series" category;trademark number 1289686, application status: "registered, live" registered on 2009-03-13 in the "word" category.

Details for ABN 33097483068

Type: Australian Private Company

ABN Status

Status From To
Active 13th July 2001 current

Main Name

Name From To
Cephalon Australia (vic) Pty Ltd 24th February 2010 current
Arana Therapeutics (vic) Pty Ltd 3rd December 2007 24th February 2010
Evogenix Limited 8th July 2005 3rd December 2007
Evogenix Pty Limited 8th May 2002 8th July 2005
Evogenix Pty Ltd 13th December 2001 8th May 2002
Diapep Pty Limited 26th July 2001 13th December 2001

Business Names

Name From To
Evogenix 13th September 2001 15th December 2010

Main Location

Location From To
NSW 2113 19th June 2015 current
VIC 3052 23rd September 2014 19th June 2015
VIC 3052 20th January 2014 23rd September 2014
VIC 3052 10th March 2008 20th January 2014
NSW 2113 27th February 2008 10th March 2008
NSW 2000 8th August 2006 27th February 2008
NSW 2000 26th July 2001 8th August 2006

Goods & Services Tax (GST)

Status From To
Registered 13th July 2001 current

Advertisements

Company Trademarks

Trademark number: 915085

General information:
Application date: 3rd June 2002
Lodgement date: 3rd June 2002
Registered date: 3rd June 2002
Live or dead: Live
CPI status: Registered
Status: Registered/Protected
Mark code: Trade Mark
Trademark type: Word
Acceptance due date: 17th September 2002
Sealing due date: 3rd April 2003
Registered from date: 3rd June 2002
Sealing date: 12th February 2003
Renewal due date: 3rd June 2022
Court orders: No
Revocation of the acceptance: No
Goods and services assistance: No
Lodgement type: National
Descriptive: Evogene
Examination report number: 1
Examination class count: 1
NICE class code: 42
NICE occ number: 1
NICE description text: Scientific And Industrial Research Services In The Field Of Biotechnology; Consultancy Assistance, Analysis And Testing In The Scientific, Technical, Pharmaceutical, Biological, Genomic Fields And In Relation To Proteins And Peptides; Development And Exploitation Of An Information Platform In The Form Of An Electronic Network For Electronic Delivery Of Data; Filing And Exploitation Of Patents And Licensing Of Intellectual Property
Applicant information:
Suburb name: Sydney
Postcode: 2000
Australian state code: NSW
Country code: AU
Attorney information:
Attorney code: 353306
Agency code: RI
Transaction type: Address for service of the trademark
Suburb name: Sydney
Postcode: 2000
Australian state codee: NSW
Attorney type: Attorney
Country code: AU

Trademark number: 921009

General information:
Application date: 24th July 2002
Lodgement date: 24th July 2002
Registered date: 24th July 2002
Live or dead: Live
CPI status: Registered
Status: Registered/Protected
Mark code: Trade Mark
Trademark type: Word series
Acceptance due date: 7th November 2002
Sealing due date: 21st May 2003
Registered from date: 24th July 2002
Sealing date: 31st March 2003
Renewal due date: 24th July 2022
Court orders: No
Revocation of the acceptance: No
Goods and services assistance: No
Lodgement type: National
Descriptive: Evibody ; Evibodies
Examination report number: 1
Examination class count: 1
NICE class code: 42
NICE occ number: 1
NICE description text: Scientific And Industrial Research Services In The Field Of Biotechnology; Consultancy Assistance, Analysis And Testing In The Scientific, Technical, Pharmaceutical, Biological, Genomic Fields And In Relation To Proteins And Peptides; Development And Exploitation Of An Information Platform In The Form Of An Electronic Network For Electronic Delivery Of Data; Filing And Exploitation Of Patents And Licensing Of Intellectual Property
Applicant information:
Suburb name: Sydney
Postcode: 2000
Australian state code: NSW
Country code: AU
Attorney information:
Attorney code: 353306
Agency code: RI
Transaction type: Address for service of the trademark
Suburb name: Sydney
Postcode: 2000
Australian state codee: NSW
Attorney type: Attorney
Country code: AU

Trademark number: 1289686

General information:
Application date: 13th March 2009
Lodgement date: 13th March 2009
Registered date: 13th March 2009
Live or dead: Live
CPI status: Registered
Status: Registered/Protected
Mark code: Trade Mark
Trademark type: Word
Acceptance due date: 14th October 2009
Sealing due date: 29th April 2010
Registered from date: 13th March 2009
Sealing date: 12th March 2010
Renewal due date: 13th March 2019
Court orders: No
Revocation of the acceptance: No
Lodgement type: National
Descriptive: Superhumanization
Examination report number: 3
Examination class count: 1
NICE class code: 42
NICE occ number: 1
NICE description text: Scientific And Medical Research, Development Services For Designing Antibodies For Use In Therapeutics And Pharmaceuticals; Providing Information To Others In The Field Of Antibodies For Use In Therapeutics And Pharmaceuticals; Pharmaceutical Drug And Therapeutics Development; Consumer Health Product Developments And Consultation In The Field Of Antibodies For Use In Therapeutics And Pharmaceutical Drug Development
Applicant information:
Suburb name: Macquarie Park
Postcode: 2113
Australian state code: NSW
Country code: AU
Attorney information:
Attorney code: 353306
Agency code: RI
Transaction type: Address for service of the trademark
Suburb name: Sydney
Postcode: 2000
Australian state codee: NSW
Attorney type: Attorney
Country code: AU

Company Patents

Patent Application Number: 2003277980

General information:

Application date: 20th April 2005
Patent status: Lapsed

Either the application has not been accepted by 21 months after the first examination report (or 12 months after the Raising the Bar Act) or some other deadline in the prosecution process has not been completed in time, for example IP Australia has issued a direction to file a request for examination and the applicant has not done so in the required period (2 months).

Patent type: NPE
Primary IPC mark: C07D 405/04
WIPO Application Number: WO2004/039995
Original WIPO Application Number: WO04/39995
PCT Application Number: PCT/AU2003/001455
Original PCT Application Number: PCT/AU03/01455

International Patent Classification:

IPC Mark: C12N 15/10
Version date of the IPC Classification record: 1st January 2006
Section code: C - chemistrymetallurgy
Class code: 12 - biochemistry; beer; spirits; wine; vinegar; microbiology; enzymology; mutation or genetic engineering
Subclass code: N - micro-organisms or enzymes; compositions thereof (biocides, pest repellants or attractants, or plant growth regulators containing micro-organisms, viruses, microbial fungi, enzymes, fermentates, or substances produced by, or extracted from, micro-organisms or animal material a01n0063000000; medicinal preparations a61k; fertilisers c05f); propagating, preserving, or maintaining micro-organisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000)
Main group code: 15 - mutation or genetic engineering; dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; use of hosts therefor (mutants or genetically engineered micro-organisms c12n0001000000, c12n0005000000, c12n0007000000; new plants a01h; plant reproduction by tissue culture techniques a01h0004000000; new animals a01k0067000000; use of medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases, gene therapy a61k0048000000; peptides in general c07k)
Subgroup code: 10 - processes for the isolation, preparation or purification of dna or rna (chemical preparation of dna or rna c07h0021000000; preparation of non-structural polynucleotides from micro-organisms or with enzymes c12p0019340000)
Mark type: Later (ie Secondary)
Classification level: Advanced
Classification code: Inventive
IPC Classification assigned/Application publish date: 8th October 2005
Classification type code: Original
Classification source code: Machine using propagation

IP Australia process information:

Source code: PAMS
Patent classification type: Standard
Examination request date: 21st November 2006
Examination request filing date: 27th April 2007
Requested examination type: Request Full Examination
First report issue date: 4th September 2008
Examination section: C2 Chemistry
Expiry date: 3rd November 2023
Earliest priority date: 1st November 2002
WIPO publication date: 13th May 2004
Effective patent date: 3rd November 2003
OPI published in journal date: 24th June 2004
Continue renew fee paid date: 2nd October 2009
Patent in force to: 3rd November 2010

Early terminations:

Application status: Lapsed
Applied date: 5th June 2010
Reason description: Did Not Gain Acceptance Within The Prescribed Time.
Published date: 1st July 2010

Patent Application Number: 1999028204

General information:

WIPO Application Number: WO1999/045110
Original WIPO Application Number: WO99/45110
PCT Application Number: PCT/AU1999/000136
Original PCT Application Number: PCT/AU99/00136
Old Application Number: 28204/99

International Patent Classification:

IPC Mark: C07K 14/745
Version date of the IPC Classification record: 1st January 2006
Section code: C - chemistrymetallurgy
Class code: 7 - organic chemistry
Subclass code: K - peptides (peptides containing -lactam rings c07d; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d; ergot alkaloids of the cyclic peptide type c07d0519020000; genetic engineering processes for obtaining peptides c12n0015000000)
Main group code: 14 - peptides having more than 20 amino acids; gastrins; somatostatins; melanotropins; derivatives thereof
Subgroup code: 745 - blood coagulation or fibrinolysis factors
Mark type: Later (ie Secondary)
Classification level: Advanced
Classification code: Inventive
IPC Classification assigned/Application publish date: 8th April 2006
Classification type code: Reclassification
Classification source code: Machine using propagation

IP Australia process information:

Source code: PATADMIN
Mainframe patent number: 747637
Patent classification type: Standard
Examination request date: 11th October 2000
Examination request filing date: 15th March 2001
Requested examination type: Full Examination Following Direction
First report issue date: 12th November 2001
Examination section: A2
Expiry date: 5th March 2019
Earliest priority date: 6th March 1998
Acceptance Notice date: 16th May 2002
Sealing date: 29th August 2002
Effective patent date: 5th March 1999
OPI published in journal date: 18th November 1999
Continue renew fee paid date: 23rd February 2015
Patent in force to: 5th March 2016

Change of Ownership:

Request filed date: 18th December 2008
Name change date: 8th January 2009
Advertised date: 29th January 2009
Change reason: Change of Name of Patentee under Reg 10.7(1)(a)(ii)
Assignment validated date: 18th July 2008
Document description: ASIC Extract
Name type: Old

Patent Application Number: 2005316193

General information:

Application date: 4th April 2007
Patent status: Sealed

What happens 3 months after acceptance, assuming there are no oppositions filed. The Status 'sealed' was replaced with 'granted' with IP reform implementation, but from a systems perspective the two statuses are identical.

Patent type: NPE
Primary IPC mark: C07K 14/715
WIPO Application Number: WO2006/063390
Original WIPO Application Number: WO06/63390
PCT Application Number: PCT/AU2005/001877
Original PCT Application Number: PCT/AU05/01877
Accepted claims count: 26

International Patent Classification:

IPC Mark: A61K 38/17
Version date of the IPC Classification record: 1st January 2006
Section code: A - human necessities
Class code: 61 - medical or veterinary science; hygiene
Subclass code: K - preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l)
Main group code: 38 - medicinal preparations containing peptides (peptides containing beta-lactam rings a61k0031000000; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, a61k0031000000; ergoline-based peptides a61k0031480000; containing macromolecular compounds having statistically distributed amino acid units a61k0031740000; medicinal preparations containing antigens or antibodies a61k0039000000; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, a61k0047000000)
Subgroup code: 17 - from animals; from humans
Mark type: Later (ie Secondary)
Classification level: Advanced
Classification code: Inventive
IPC Classification assigned/Application publish date: 22nd June 2006
Classification type code: Original
Classification source code: Human

IP Australia process information:

Source code: PAMS
Patent classification type: Standard
Examination request date: 15th May 2009
Examination request filing date: 20th October 2009
Requested examination type: Request Full Examination
First report issue date: 15th December 2010
Further report issue date: 28th September 2011
Expiry date: 13th December 2025
Earliest priority date: 13th December 2004
Acceptance Notice date: 17th May 2012
Sealing date: 30th August 2012
WIPO publication date: 22nd June 2006
Effective patent date: 13th December 2005
Continue renew fee paid date: 9th December 2013
Patent in force to: 13th December 2014

Change of Ownership:

Request filed date: 9th September 2010
Name change date: 21st September 2010
Advertised date: 30th September 2010
Change reason: Alteration of Name(s) of Applicant(s) under S113

Find company

NSW 2113 Location

2024 © aubiz.net - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us: info@aubiz.net
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.